Oncogenic Transcription Factors in the Human Acute Leukemias
- 7 November 1997
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 278 (5340) , 1059-1064
- https://doi.org/10.1126/science.278.5340.1059
Abstract
Chromosomal translocations in the human acute leukemias rearrange the regulatory and coding regions of a variety of transcription factor genes. The resultant protein products can interfere with regulatory cascades that control the growth, differentiation, and survival of normal blood cell precursors. Support for this interpretation comes from the results of gene manipulation studies in mice, as well as the sequence homology of oncogenic transcription factors with proteins known to regulate embryonic development in primitive organisms, including the nematode Caenorhabditis elegans and the fruit fly Drosophila melanogaster . Many of these genetic alterations have important prognostic implications that can guide the selection of therapy. The insights gained from studies of translocation-generated oncogenes and their protein products should hasten the development of highly specific, and hence less toxic, forms of leukemia therapy.Keywords
This publication has 62 references indexed in Scilit:
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- Chimeric oncoprotein E2a-Pbx1 induces apoptosis of hematopoietic cells by a p53-independent mechanism that is suppressed by Bcl-2Oncogene, 1997
- Regulation of gene expression by small moleculesNature, 1997
- HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpointNature, 1997
- Overexpression of HOXB3 in Hematopoietic Cells Causes Defective Lymphoid Development and Progressive MyeloproliferationImmunity, 1997
- Reversal of apoptosis by the leukaemia-associated E2A–HLF chimaeric transcription factorNature, 1996
- Altered Hox expression and segmental identity in Mll-mutant miceNature, 1995
- Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL) by All Transretinoic Acid (ATRA) Combined with Chemotherapy: The European ExperienceLeukemia & Lymphoma, 1995
- A New Transcription Factor Family Associated with Human LeukemiasCritical Reviews™ in Eukaryotic Gene Expression, 1995
- Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cellsNature, 1988